Related Experiment Video
Updated: Jul 21, 2025

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa
Published on: February 17, 2014
Molecular determinants of avoidance and inhibition of Pseudomonas aeruginosa MexB efflux pump
Silvia Gervasoni1, Jitender Mehla2, Charles R Bergen2
1Department of Physics, University of Cagliari , Monserrato, Italy.
Abstract:
Transporters of the resistance-nodulation-cell division (RND) superfamily of proteins are the dominant multidrug efflux power of Gram-negative bacteria. The major RND efflux pump of Pseudomonas aeruginosa is MexAB-OprM, in which the inner membrane transporter MexB is responsible for the recognition and binding of compounds. The high importance of this pump in clinical antibiotic resistance made it a subject of intense investigations and a promising target for the discovery of efflux pump inhibitors. This study is focused on a series of peptidomimetic compounds developed as effective inhibitors of MexAB-OprM. We performed multi-copy molecular dynamics simulations, machine-learning (ML) analyses, and site-directed mutagenesis of MexB to investigate interactions of MexB with representatives of efflux avoiders, substrates, and inhibitors. The analysis of both direct and water-mediated protein-ligand interactions revealed characteristic patterns for each class, highlighting significant differences between them. We found that efflux avoiders poorly interact with the access binding site of MexB, and inhibition engages amino acid residues that are not directly involved in binding and transport of substrates. In agreement, machine-learning models selected different residues predictive of MexB substrates and inhibitors. The differences in interactions were further validated by site-directed mutagenesis. We conclude that the substrate translocation and inhibition pathways of MexB split at the interface (between the main putative binding sites) and at the deep binding pocket and that interactions outside of the hydrophobic patch contribute to the inhibition of MexB. This molecular-level information could help in the rational design of new inhibitors and antibiotics less susceptible to the efflux mechanism. IMPORTANCE Multidrug transporters recognize and expel from cells a broad range of ligands including their own inhibitors. The difference between the substrate translocation and inhibition routes remains unclear. In this study, machine learning and computational and experimental approaches were used to understand dynamics of MexB interactions with its ligands. Our results show that some ligands engage a certain combination of polar and charged residues in MexB binding sites to be effectively expelled into the exit funnel, whereas others engage aromatic and hydrophobic residues that slow down or hinder the next step in the transporter cycle. These findings suggest that all MexB ligands fit into this substrate-inhibitor spectrum depending on their physico-chemical structures and properties.
Insights
Researchers investigated how the MexAB-OprM efflux pump in bacteria interacts with substrates and inhibitors. They found distinct binding patterns, suggesting separate pathways for substrate transport and inhibitor action, aiding in designing new drugs.
Area of Science:
- Microbiology and Molecular Biology
- Drug Discovery and Development
Background:
- Resistance-nodulation-cell division (RND) superfamily proteins are key multidrug efflux pumps in Gram-negative bacteria.
- The MexAB-OprM pump in *Pseudomonas aeruginosa* is crucial for clinical antibiotic resistance and a target for inhibitor development.
Purpose of the Study:
- To investigate the molecular interactions of the MexB transporter with efflux avoiders, substrates, and inhibitors.
- To elucidate the distinct mechanisms of substrate translocation and inhibitor binding within the MexB pump.
Main Methods:
- Multi-copy molecular dynamics simulations.
- Machine-learning (ML) analyses.
- Site-directed mutagenesis of MexB.
Main Results:
- Distinct interaction patterns were identified between MexB and substrates versus inhibitors.
- Efflux avoiders showed weak interaction with MexB's access binding site; inhibition involved residues outside substrate binding sites.
- ML models differentiated residues predictive of substrates and inhibitors, validated by mutagenesis.
Conclusions:
- Substrate translocation and inhibition pathways in MexB diverge, utilizing different binding sites and residues.
- Inhibition involves interactions beyond the hydrophobic patch, offering insights into pump evasion mechanisms.
- Findings support rational design of novel inhibitors and antibiotics to overcome efflux-mediated resistance.
More Related Videos
10:43Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
Published on: December 3, 2010
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
Related Concept Videos
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...